We are part of the CSL Limited group of companies. See how we're Driven by Our Promise.
We collaborate with rare disease organizations to promote quality medical care and services.
We offer a variety of support programs and activities for the patients we serve.
We also aim to make sure that nothing holds you back from getting the therapies you need.
Our product portfolio focuses on innovation in new products, improved products and manufacturing expertise.
A clinical trial is a research study that is done to find out if medical treatments can improve people’s health.
We work every day as if someone’s life depends on it, because it does.
We manufacture products to treat a number of rare diseases.
Help us deliver on our promise to save lives and protect the health of people.
Diversity and inclusion are top priorities for CSL Behring.
5 Things To Know About Hemophilia B
Hemophilia B patients are missing clotting Factor IX but treatments have come a long way - with more innovation in progress.
Gene Therapy Collaboration with Seattle Children’s
CSL Behring’s R&D Head: We’re growing our capabilities in gene therapy to improve patients’ lives.
Celebrating an Expanded R&D Facility in Pasadena
CSL Behring site includes three labs and cell manufacturing space near leading academic institutions.
Patients as Partners
Healthcare panel will explore how tech can build a bridge and involve patients every step of the way.
Mining the Data Boom
The role data science plays in new medicine development.
BIO 2019 in Philadelphia
Three takeaways from physician and author Siddhartha Mukherjee
Hope Renews For Sickle Cell Disease Patients
Advances in treating rare blood disorder grab media spotlight.
Popular search terms:
Americas
Asia Pacific
Europe
This website uses cookies to improve user experience. By continuing to use this website, you consent to our use of these cookies. To learn more about how we use and manage cookies, see our Privacy Policy and Cookie Policy.
